Manufacturers - Notice of Application 2004 "Johnson Matthey Inc."

DEA Diversion Control Program Logo and Banner

Federal Register Notices > Notices of Application - 2004 > Johnson Matthey Inc.

Notices of Application - 2004

FR Doc 04-16386 [Federal Register: July 20, 2004 (Volume 69, Number 138)] [Notices] [Page 43436] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr20jy04-72]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substance; Notice of Application

Pursuant to 21 CFR 1301.33(a), this is notice that on June 7, 2004, Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of Dihydromorphine (9145), a basic class of controlled substance listed in Schedule I.

The company plans to manufacturer Dihydromorphine for internal use in production of other controlled substances for distribution to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistance Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD) and must be filed not later than September 20, 2004.

Dated: July 8, 2004.

William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 04-16386 Filed 7-19-04; 8:45 am]

BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

Back to Top